Orthofix saw first quarter 2025 sales grow, according to financial results posted May 6.
Five things to know about Q1:
1. Orthofix’s sales, including its recently discontinued M6-C and M6-L disc, were $193.6 million. Excluding M6 sales, Orthofix’s quarterly revenue grew 3.9% with $189.2 million.
2. Global spine sales of $159 million represent a 3% increase year over year.
3. Global orthopedic sales increased 9.1% year over year with $29.8 million.
4. Orthofix operated with a net loss of $53.1 million. That net loss grew year over year compared to a $36 million net loss in the same time last year.
5. Orthofix projects its full year revenue to reach $808 million to $816 million, excluding M6 sales.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.